Showing results (201-210 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|June 29, 2014
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trialMichael P Boyle, Scott C Bell, Michael W Konstan, et al.
The Lancet. Respiratory Medicine|February 10, 2015
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trialNeal Navani, Matthew Nankivell, David R Lawrence, et al.
The Lancet. Respiratory Medicine|July 21, 2022
Pulmonary manifestations of chronic HPV infection in patients with recurrent respiratory papillomatosisSara I Pai, Isaac Wasserman, Yisi D Ji, et al.
The Lancet. Respiratory Medicine|May 22, 2023
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitationSally J Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet. Respiratory Medicine|March 16, 2023
Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statementMatteo Di Nardo, Graeme MacLaren, Peter Schellongowski, et al.
The Lancet. Respiratory Medicine|March 9, 2023
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialKeiju Aokage, Kenji Suzuki, Hisashi Saji, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysisNicholas Winters, Robert Belknap, Andrea Benedetti, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Pageof 103